This inventor holds 2 USPTO granted patents. Top assignees: Foundation for Biomedical Research and Innovation, Hokkaido University, Hyogo College of Medicine. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 17 
2 out of 442 
2 out of 13 
Years Active: 2019-2022
Title: Innovations by Shunsuke Ohnishi in Mesenchymal Stromal Cell Research
Introduction
Shunsuke Ohnishi is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of biomedical research, particularly in the area of mesenchymal stromal cells (MSCs). With a total of two patents to his name, Ohnishi's work focuses on innovative methods for producing and preserving these valuable cells.
Latest Patents
Ohnishi's latest patents include a method for producing an amniotic mesenchymal stromal cell composition and a method for cryopreserving the same. The primary objective of his invention is to provide a convenient and aseptic method for separating high-purity amnion-derived MSCs through a single enzyme treatment. This process involves treating the amnion with collagenase and thermolysin and/or dispase, followed by filtering the enzyme-treated amnion through a mesh. Additionally, he has developed a therapeutic agent that utilizes the mesenchymal stromal cell composition for treating various diseases, including graft-versus-host disease, inflammatory bowel disease, systemic lupus erythematosus, liver cirrhosis, and radiation enteritis.
Career Highlights
Throughout his career, Ohnishi has worked with esteemed organizations such as the National Cerebral and Cardiovascular Center and the Foundation for Biomedical Research and Innovation at Kobe. His
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile